Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Department of Cell and Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
J Cell Sci. 2017 Dec 1;130(23):4051-4062. doi: 10.1242/jcs.208983.
The post-mitotic midbody (MB) is a remnant of cytokinesis that can be asymmetrically inherited by one of the daughter cells following cytokinesis. Until recently, the MB was thought to be degraded immediately following cytokinesis. However, recent evidence suggests that the MB is a protein-rich organelle that accumulates in stem cell and cancer cell populations, indicating that it may have post-mitotic functions. Here, we investigate the role of FYCO1, an LC3-binding protein (herein, LC3 refers to MAP1LC3B), and its function in regulating the degradation of post-mitotic MBs. We show that FYCO1 is responsible for formation of LC3-containing membrane around the post-mitotic MB and that FYCO1 knockdown increases MB accumulation. Although MBs accumulate in the stem-cell-like population of squamous cell carcinomas, FYCO1 depletion does not affect the clonogenicity of these cells. Instead, MB accumulation leads to an increase in anchorage-independent growth and invadopodia formation in HeLa cells and squamous carcinoma cells. Collectively, our data suggest that FYCO1 regulates MB degradation, and we present the first evidence that cancer invasiveness is a feature that can be modulated by the accumulation of MBs in cancer stem cells.This article has an associated First Person interview with the first author of the paper.
有丝分裂后中期体(MB)是胞质分裂的残留物,在胞质分裂后可以不对称地遗传给一个子细胞。直到最近,MB 被认为在胞质分裂后立即降解。然而,最近的证据表明,MB 是一种富含蛋白质的细胞器,在干细胞和癌细胞群体中积累,表明它可能具有有丝分裂后功能。在这里,我们研究了 FYCO1 的作用,FYCO1 是一种 LC3 结合蛋白(在此,LC3 是指 MAP1LC3B),及其在调节有丝分裂后 MB 降解中的作用。我们表明 FYCO1 负责形成有丝分裂后 MB 周围含有 LC3 的膜,FYCO1 敲低会增加 MB 的积累。尽管 MB 在鳞状细胞癌的干细胞样群体中积累,但 FYCO1 耗竭并不影响这些细胞的集落形成能力。相反,MB 的积累导致 HeLa 细胞和鳞状癌细胞中锚定非依赖性生长和侵袭伪足形成的增加。总之,我们的数据表明 FYCO1 调节 MB 的降解,我们首次提出证据表明,癌症侵袭性是可以通过 MB 在癌症干细胞中的积累来调节的特征。本文有一篇与该论文第一作者的第一人称访谈。